Study | Outcome | MICD | Findings (Positive MD favours shorter wait) | Statistical Significance | Clinical Significance |
---|---|---|---|---|---|
Aamot et al (2010) [44] | Exercise Tolerance (VO2 Peak) | 3.1 ml/Kg per min | MD 0.1 (95%CI -5.2 to 5.4) | N | N |
QOL: | Â | Â | Â | Â | |
 SF-36 General Health | 4.4 units | MD -4 (-8.3 to 0.3) | N | N | |
 SF-36 Role Physical | 12.5 units | MD -8.3 (95%CI -18.0 to 1.5) | N | N | |
 SF-36 Physical Functioning | 8.1 units | MD 3.8 (95%CI -2.2 to 9.7) | N | N | |
Fell et al (2016) [46] | Physical Activity (Guideline adherence) | 150 min/week | Long wait group: OR 0.9 (95%CI 0.7 to 1.0) | N | N |
Exercise Tolerance (Shuttle walk test) | ≥70 m | Long wait group: OR 0.8 (95%CI 0.7 to 0.9) | Y | Y | |
QOL (Dartmouth self-reported fitness) | 1-3 (healthy status score) | Long wait group: OR 0.8 (95%CI 0.7 to 0.9) | Y | Y | |
Johnson et al (2014) [47] | Exercise Tolerance (MET change scores) | 0.5 METs | Short wait vs. intermediate wait: MD 0.6 (95%CI 0.3 to 1.0) | Y | Y |
Short wait vs. long wait: MD 1.2 (95%CI 0.9 to 1.6) | Y | Y | |||
Kehler et al (2017) [48] | Physical Activity (Guideline adherence) | 150 mins/week | Short wait vs. long wait: 83% vs. 60% | N | N |
Exercise Tolerance (MET) | 0.5 METs | MD 2 (95%CI 0.6 to 3.4) | Y | Y | |
Depressive symptoms (PHQ-9) | 5 units | MD 0.9 (95%CI -1.4 to 3.2) | N | N | |
Marzolini et al (2015) [50] | Exercise Tolerance (VO2 Peak) | 8.5 ml/Kg per min | MD 14.5 (95%CI 10.0 to 18.1) | Y | Y |
Pack et al (2013) [43] | Exercise Tolerance (MET) | 0.5 METs | MD 0.1 (95%CI -0.3 to 0.5) | N | N |